Trisomy 7 by dual-color fluorescence in situ hybridization: a potential biological marker for prostate cancer progression.
Smear preparations from fine-needle aspirates of 30 prostatic carcinomas obtained from radical prostatectomy specimens were examined by a dual-color fluorescence in situ hybridization (FISH) method for the presence of chromosome 7 trisomy (chromosome 9 was used as a control). The frequency of cells with trisomy 7 was determined in tumor cells and normal prostatic epithelial cells in each specimen. Comparison between the tumor and normal cells from the same patients showed that within all stages, the frequency of trisomy 7/disomy 9 cells in the tumor cells was significantly higher than that observed in the normal cells (P < 0.0001). Furthermore, the mean frequency of cells with trisomy 7/disomy 9 in advanced stages was significantly elevated over the mean frequency observed in organ-confined tumors (P = 0.02). These results are consistent with our previous data on paraffin-embedded prostate tissue sections using single-color FISH procedures. However, the method used in the present study enhances the accuracy of distinguishing trisomic 7 cells from potentially triploid (trisomy 7/trisomy 9) cells. Furthermore, the use of fine-needle aspirates rather than paraffin sections provides an easy method to examine whole nuclei. Our study also suggests that FISH provides a better measure of genetic instability (e.g., aneuploidy) in prostate tumors than flow cytometry.